Literature DB >> 12154220

Pneumocystis carinii pneumonia following a second infusion of infliximab.

T L Tai, K P O'Rourke, M McWeeney, C M Burke, K Sheehan, M Barry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12154220     DOI： 10.1093/rheumatology/41.8.951

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  15 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

2.  Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.

Authors:  Christina M Coyle; Louis M Weiss; Luther V Rhodes; Ann Cali; Peter M Takvorian; Daniel F Brown; Govinda S Visvesvara; Lihua Xiao; Jaan Naktin; Eric Young; Marcelo Gareca; Georgia Colasante; Murray Wittner
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

Review 3.  Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

4.  Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells.

Authors:  Amy C Herring; Nicole R Falkowski; Gwo-Hsiao Chen; Rod A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 5.  Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

Authors:  D C Sadowski; C N Bernstein; A Bitton; K Croitoru; R N Fedorak; A Griffiths
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

Review 6.  Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Authors:  James A Grubbs; John W Baddley
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

Review 7.  Listeria meningitis complicating a patient with ulcerative colitis on concomitant infliximab and hydrocortisone.

Authors:  V Parihar; S Maguire; A Shahin; Z Ahmed; M O'Sullivan; M Kennedy; C Smyth; R Farrell
Journal:  Ir J Med Sci       Date:  2015-09-10       Impact factor: 1.568

Review 8.  [Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review].

Authors:  B Bertisch; C Ruef
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

Review 9.  Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors:  Martin Rodriguez; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Listeria meningitis complicating infliximab treatment for Crohn's disease.

Authors:  Geoffrey Williams; Asad A Khan; Franzjosef Schweiger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.